Combining human telomerase reverse transcriptase (hTERT) vaccination with anti-CTLA4 therapy led to an elevated tumor IFN-γ signature, while blood biopsies showed T-cell receptor (TCR) clones enriched by vaccination—indicating a robust immune response. The gene discussed is CTLA4; the disease is neoplasm.